Search for: "Novartis Pharmaceuticals Corp." Results 21 - 40 of 366
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Apr 2019, 7:31 am by BTugendstein
According to Law360, in late February 2019, a New Jersey jury returned a verdict of over $1.8 million in favor of Min Amy Guo, a whistleblower who alleged that Novartis Pharmaceuticals Corp. terminated her for retaliatory reasons in violation of CEPA. [read post]
23 May 2010, 7:56 am by Peter M. LaSorsa
Novartis Pharmaceuticals Corp. must pay $250 million in punitive damages for a gender discrimination lawsuit. [read post]
15 Feb 2015, 9:43 pm by Patent Docs
Ezra Ventures LLC 1:15-cv-00150; filed February 11, 2015 in the District Court of Delaware • Plaintiffs: Novartis AG; Novartis Pharmaceuticals Corp.; Mitsubishi Tanabe Pharma Corp.; Mitsui Sugar Co. [read post]
27 Jan 2012, 6:00 am by Keith Reinfeld
SmithKline Beecham Corp., that held a proposed class of pharmaceutical sales representatives to be exempt from overtime pay pursuant to the “outside sales exemption. [read post]
24 Feb 2013, 9:06 pm by Patent Docs
Novartis Pharmaceuticals Corp. v. [read post]
19 Jul 2010, 6:10 pm by Buckley & Klein
In a recent decision, the Second Circuit determined that Novartis Pharmaceutical Corps representatives were not covered by the “outside sales” exemption under the Fair Labor Standards Act and hence, were entitled to overtime pay. [read post]
29 Jun 2014, 9:21 pm by Patent Docs
Novartis Pharmaceuticals Corp. et al. v. [read post]
28 Dec 2014, 9:49 pm by Patent Docs
Novartis Pharmaceuticals Corp. et al. v. [read post]
8 Nov 2009, 9:28 pm
Apotex Inc. et al. 1:09-cv-06950; filed November 4, 2009 in the Northern District of Illinois • Plaintiffs: Novartis AG; Novartis Pharmaceuticals Corp. [read post]
30 Sep 2010, 5:03 am by Ben Vernia
Right on schedule to end the fiscal year, DOJ announced on September 30 that Novartis Pharmaceuticals Corp. has agreed to plead guilty to a misdemeanor and pay criminal and civil fines and damages. [read post]
8 Mar 2011, 6:57 am by Rob Stalter
Just weeks after the Ninth Circuit created a circuit split by ruling that pharmaceutical sales representatives are exempt under the Fair Labor Standards Act's outside sales exemption (see our earlier post on that decision), the Supreme Court has declined to hear Novartis Pharmaceutical Corp.'s appeal of a Second Circuit decision reaching the opposite conclusion. [read post]
12 Apr 2017, 9:52 am by Lawrence B. Ebert
Patent No.8,324,283 (the ’283 patent), owned by Novartis AG andMistubishi Tanabe Pharma Corp. [read post]
13 Apr 2014, 9:43 pm by Patent Docs
Novartis Pharmaceuticals Corp. et al. v. [read post]
9 Feb 2014, 9:15 pm by Patent Docs
Novartis Pharmaceuticals Corp. et al. v. [read post]